Trial intelligence / Profile preview

Immune response to inactivated oral cholera vaccine (Dukoral) in renal transplant recipients

2010-018377-38Phase 4Active

Sponsor
Leiden University Medical Center
Start
Jan 2010
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of cholera toxin B subunit in cholera (3 arms), sponsored by Leiden University Medical Center. Primary endpoint: Seroconversion rate. Started Jan 2010; status: active.

02

Drugs

cholera toxin B subunit
03

Conditions

cholera

Beyond the preview

Go deeper on 2010-018377-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-018377-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call